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Abstract
Background: This study examined the variation in city-level amenable mortality, i.e. mor-
tality due to conditions that can be mitigated in the presence of timely and effective
healthcare, in 363 Latin American cities and measured associations between amenable-
mortality rates and urban metrics.
Methods: We used death records from 363 cities with populations of >100 000 people in
nine Latin American countries from 2010 to 2016. We calculated sex-specific age-ad-
justed amenable-mortality rates per 100 000. We fitted multilevel linear models with cit-
ies nested within countries and estimated associations between amenable mortality and
urban metrics, including population size and growth, fragmentation of urban develop-
ment and socio-economic status.
Results: Cities in Mexico, Colombia and Brazil had the highest rates of amenable mortal-
ity. Overall, >70% of the variability in amenable mortality was due to between-country
heterogeneity. But for preventable amenable mortality, those for which the healthcare
system can prevent new cases, most of the variability in rates occurred between cities
within countries. Population size and fragmentation of urban development were
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associated with amenable mortality. Higher fragmentation of urban development was as-
sociated with lower amenable mortality in small cities and higher amenable mortality in
large cities. Population growth and higher city-level socio-economic status were associ-
ated with lower amenable mortality.
Conclusions: Most of the variability in amenable mortality in Latin American cities was
due to between-county heterogeneity. However, urban metrics such as population size
and growth, fragmentation of urban development and city-level socio-economic status
may have a role in the distribution of amenable mortality across cities within countries.
Key words: Amenable mortality, urban health, Latin America
Introduction
Deaths amenable to healthcare are deaths attributed to
conditions that can be mitigated in the presence of timely
and effective healthcare.1 Examples include deaths due to
ischaemic heart disease and tuberculosis among those aged
<74 years and deaths due to diabetes among those aged
<49 years.2 Although studies have examined amenable
mortality in a number of high-income countries,3,4 less is
known about amenable mortality in Latin American coun-
tries.2,5 In addition, little attention has been given to sub-
national variation, specifically variation in amenable
mortality among cities within countries.
Over the past 30 years, Latin American countries have
greatly expanded healthcare coverage for their citizens.6
Some countries, e.g. Brazil and Costa Rica, have created
tax-financed universal healthcare systems where health
services are available to all residents. Other countries, e.g.
Argentina, Chile, Mexico and Peru, have expanded their
healthcare coverage by subsidizing health insurance for the
poor and uninsured, and pooling together funds from
workers’ contributions and general taxes.7 As a result,
countries in the region have greatly improved the coverage
of health services and narrowed the gap in healthcare utili-
zation.7,8 Despite this progress, issues around the quality
of care received and care coordination for people with
chronic conditions continue to be major barriers to im-
proving population health.2,9 In addition, there is potential
for large local variation in access to quality healthcare
across geographies.10
In Latin America, as in low- and middle-income coun-
tries across other regions, a growing proportion of the pop-
ulation live in urban areas.11 The characteristics of the
built environment in these cities may be determinant for
access to quality healthcare.10,12 Historically, large cities in
Latin America concentrate a significant portion of the
countries’ healthcare resources, from infrastructure to hu-
man capital.13–16 Furthermore, the spatial configuration of
cities may be associated with geographic barriers to health-
care access.10 Urban development that is discontinuous
and spread out, i.e. urban-development fragmentation, is
associated with increases in the cost of public services, traf-
fic congestion and air pollution;17,18 this fragmentation
may be an indicator of barriers to access to services in gen-
eral, and healthcare services in particular. For example,
Key Messages
• Rates of healthcare amenable mortality varied greatly in Latin American cities. A large share of the variation in
amenable mortality for chronic and acute conditions was due to heterogeneity between countries.
• Cities in Mexico, Colombia and Brazil had the highest rates of amenable mortality, whereas cities in Argentina, Chile,
Costa Rica and Panama had lower amenable-mortality rates compared with cities in other countries.
• Although a large share of the heterogeneity in amenable mortality in Latin American cities can be explained by
country-level factors or by compositional differences across countries, city-level factors also play a role in driving
rates of amenable mortality. In particular, high levels of urban-development fragmentation were associated with
higher amenable mortality in large cities but lower amenable mortality in small cities. Cities with high socio-
economic levels had relatively lower rates of amenable mortality.
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urban-development fragmentation may limit geographic
access among populations living in the peripheral areas of
large urban centres, potentially reducing the benefits of liv-
ing in a large city with relatively high availability of serv-
ices but where services are distributed unevenly.
Socio-economic factors also play a role in access to
healthcare;19 wealthier cities are more likely to concentrate
healthcare resources as well as a large labour pool which,
in turn, attracts populations from other areas of the coun-
try.20 On the other hand, rapid population growth could
lead to increased demand for services for which the health-
care system is not prepared to provide. Examining the role
of these urban features on amenable mortality may have
the potential to inform policies to improve health out-
comes among residents of Latin American cities and other
low- and middle-income regions in the world.
The aims of this paper are: (i) to estimate the rates of
mortality amenable to healthcare in 363 Latin American
cities, including the share of city variability between and
within countries; and (ii) to explore the relationships of ur-
ban metrics, including population size, population growth,
urban-development fragmentation and city-level socio-eco-
nomic status, with amenable-mortality rates.
Methods
Study setting
We used data from the Salud Urbana en America Latina
(SALURBAL) project.21,22 This project has compiled and har-
monized health and environmental data for 371 cities with
populations of >100 000 people in 11 Latin American coun-
tries. Cities were defined as urban agglomerations of local ad-
ministrative units that encompassed the urban extent or
footprint of a city. For this analysis, we used data from 363
SALURBAL cities in nine Latin American countries
(Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico,
Panama, Peru and El Salvador). We used data from 2012
to 2016 for all countries except El Salvador, for which
we had data available from 2010 to 2014. The sources of
mortality data and population denominators are listed in
Supplementary Table S1 (available as Supplementary data at
IJE online), whereas sources for all other data are available
elsewhere.23 The SALURBAL study protocol was approved
by the Drexel University Institutional Review Board with
ID#1612005035.
Outcome variables
Healthcare amenable deaths were defined using the codes
recommended by Kruk and colleagues.2 This list of codes
includes the conditions identified by Nolte and McKee1
and conditions included by Goal 3 of the Sustainable
Developmental Goals (to ensure healthy lives and promote
well-being for all at all ages) for which risk of death can be
reduced by the use of personal healthcare. Amenable
deaths were classified into three groups: (i) acute condi-
tions that are treated or cured with episodic care, e.g.
ischaemic heart disease and road injuries; (ii) chronic con-
ditions requiring sustained care to either cure or prevent se-
quelae, e.g. diabetes and breast cancer; and (iii) conditions
for which healthcare can prevent new cases, e.g. tuberculo-
sis and cervical cancer (see the complete list of conditions
in Supplementary Table S2, available as Supplementary
data at IJE online).2 Population data for denominators
were from population projections by age, sex and city, pro-
vided by local census bureaus.22 The main outcome of this
study was sex-specific age-adjusted amenable mortality per
100 000, overall and by the three groups of amenable con-
ditions, for each city, calculated using the direct method of
standardization with the 2000–2025 WHO standard
population.24
We corrected for the incomplete coverage of all death
counts25 using an ensemble of death-distribution methods
at the city level, stratified by sex. To address the potential
violation of the assumption of no net migration for these
methods, we used two approaches. First, we calculated
completeness of death registration using three death-distri-
bution methods that respond differentially to migra-
tion:25,26 (i) the generalized growth balance method
(GGB), (ii) the synthetic extinct generations method (SEG)
and (iii) the hybrid GGB-SEG method.25,26 Second, we es-
timated completeness at ages at which migration is lowest:
(i) 30–65 years, as suggested by Hill;27 (ii) 50–70 years, as
suggested by Murray;26 and (iii) best-fitting age bands25
using the R package Death Registration Coverage (DDM).
We truncated all coverage estimates of >1 to 1 (assuming
no overcounting) and averaged all nine estimates (three
methods  three age bands) using the harmonic mean.25
More details about this correction are available else-
where.23 We corrected death counts by dividing the num-
ber of deaths by the correction factor.
We also addressed deaths with an underlying cause
coded as ill-defined diseases or injuries of ill-defined intent.
We redistributed these ill-defined deaths to amenable
deaths categories or non-amenable using a proportional re-
distribution, following the Global Health Estimates (GHE)
method.28 Specifically, we fitted a multinomial model by
country with age, sex and year as predictors, and obtained
100 draws of the redistributed cause of death from this
model to acknowledge uncertainty in the redistribution.
Supplementary Figure S1 (available as Supplementary
data at IJE online) shows the distribution of completeness
and proportion of ill-defined deaths by city and country.
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Exposure variables
We used the following urban metrics as exposures: (i) the
average city population in the study period; (ii) a measure
of urban-development fragmentation, patch density, de-
fined as the number of continuous areas of urban develop-
ment per 100 square kilometres of land area; (iii)
population growth defined as the percent change in popu-
lation size between the first and last year for which mortal-
ity data were used in this analysis; and (iv) a composite
index to proxy socio-economic status (SES) based on edu-
cation attainment at the city level. This index was calcu-
lated by averaging the Z scores of two census-derived
indicators: proportion of the population aged 25 years
who had completed secondary education or above, and
proportion of the population aged 25 years who had
completed university education or above. The education
categories were harmonized across countries.22 More
details on the calculation of the patch density and the har-
monization of the education variables across the countries
can be found elsewhere.22
Covariate adjustment
We used the percentage of the area of the city that is built,
defined as the percentage of the total land area that is cov-
ered by urban patches.29 This adjustment was done to ac-
count for cities that may spread across areas that include
largely unpopulated sections of land.
Analytical approach
We first described the variability in outcomes, exposures
and covariates by city size in tabular form. We calculated
the age-standardized amenable-mortality rates by group
(acute, chronic and preventable) across all redistributions
and used the average rate in each city for descriptive pur-
poses. For aim 1, to describe the variation in healthcare
amenable mortality between and within countries, we ex-
amined amenable mortality by group, sex and country. To
quantify the degree of variability between and within coun-
tries, we modelled the log of the sex-specific age-adjusted
amenable-mortality rates using multilevel linear regression
with cities nested within countries. We used the model
below:
log yijð Þ ¼ b0 þ dj þ ijdj  N 0; s2
 
ij  N 0;r2
 
where i represents the cities within countries (j), b0 is the
average amenable mortality (intercept), dj is the random ef-
fect for each country and eij is the level-1 residual. s
2 and
r2 are the variance components that we used to calculated
intra-class correlation coefficient (ICCs) that estimate the
proportion of variation in amenable-mortality rates among
countries (between-country variability) within the total
variability [ICC¼ s2/(s2þ r2)].
For aim 2, explore the relationships between urban met-
rics and amenable mortality, we regressed the log of mor-
tality rates stratified by sex on all predictors
simultaneously: population size on the log scale, popula-
tion growth, patch density and city-level SES, adjusting for
percentage of built-up area and country fixed effects. We
also tested interactions between population size and the
other predictors, i.e. patch density, population growth and
SES index, to examine whether associations between these
predictors and amenable mortality changed in cities with
different population sizes. To facilitate the interpretation
of coefficients, all variables were standardized by subtract-
ing the mean and scaling by their standard deviation (SD).
Models were run 100 times with the redistributed mortal-
ity rates for each city. Coefficients were pooled using
Rubin’s formula.30 To check for potential issues associated
with the quality of the mortality data, we performed a sen-
sitivity analysis using the same analytical strategy as de-
scribed previously but excluding cities in El Salvador and
Peru, given the lower levels of coverage of death counts in
these countries. All analyses were performed using R ver-
sion 4.0.2 and Stata 13.31 There was no patient or public
involvement in either the design or the development of the
study.
Results
We analysed >8 million deaths over a 5-year period in 363
Latin American cities. Table 1 shows the median values for
outcome, predictors and covariates. The median age-
adjusted amenable-mortality rate was 493.3 per 100 000
(Q1–Q3¼ 420.8–558.1) for women and 838.5 per 100
000 (Q1–Q3¼ 713.9–946.5) for men. Cities with 5 mil-
lion people had the lowest amenable-mortality rates.
Among the 363 cities, the median population was 0.3 mil-
lion. Supplementary Figure S2 (available as Supplementary
data at IJE online) shows the relationship between amena-
ble-mortality rate and population as a continuous variable
in the log scale. The median 5-year population growth was
4.7% with larger growth in mid-sized cities. The median
patch density was 29.5 patches per square kilometre and
the median percentage built up was 3.5%. More-populated
cities had generally higher patch density (higher fragmenta-
tion), percentage built up and SES compared with less-pop-
ulated cities.
Figures 1 and 2 (and Supplementary Table S3, available
as Supplementary data at IJE online) show amenable-mor-
tality rates overall and for the three groups of amenable
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Table 1. Median outcomes, predictors and covariates in 363 Latin American cities by category of population size
Population size Overall 100–250 K 250–500 K 500 K–1 M 1–5 M 5 M
# Cities 363 157 97 59 43 7
Amenable mortality rate (women) 493.3 495.7 503.7 482.4 493.3 426.6
[420.8; 558.1] [412.7; 569.1] [421.5; 555.7] [415.5; 542.4] [439.2; 564.0] [313.2; 533.4]
Amenable mortality rate (men) 838.5 846.2 840.9 838.5 831.5 671.7
[713.9; 946.5] [724.6; 969.8] [681.4; 939.0] [750.9; 943] [715.8; 937.1] [571.7; 852.2]
City size (million) 0.3 0.2 0.3 0.7 1.8 12.2
[0.2; 0.6] [0.1; 0.2] [0.3; 0.4] [0.6; 0.9] [1.2; 3.1] [8.6; 20.6]
City growth (%/5 years) 4.7 4.5 4.8 5.2 4.6 3.5
[3.5; 6.4] [3.3; 6.1] [3.6; 6.7] [4.1; 6.4] [3.2; 6.2] [2.9; 4.4]
Fragmentation (patches/km2) 29.5 23.3 24.7 35.4 61.1 56.7
[11.9; 55.9] [8.9; 41.1] [10.1; 43] [16.5; 58.9] [40.2; 81.8] [43.5; 91.5]
Percentage built up (%) 3.5 2.3 2.7 4.7 10.8 23.8
[1.4; 6.6] [0.9; 4.2] [1.5; 5.8] [2.5; 7.9] [6.7; 13.1] [19.4; 27.3]
Socioeconomic Index –0.4 –1.0 –0.6 0.6 0.3 1.0
[–1.3; 0.5] [–1.7; 0.0] [–1.3; 0.4] [–0.7; 1.1] [–0.2; 0.7] [–0.3; 1.6]
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Figure 1. Amenable-mortality rates in 363 Latin American cities. AR, Argentina; BR, Brazil; CL, Chile; CO, Colombia; CR, Costa Rica; MX, Mexico; PA,
Panama; PE, Peru; SV, El Salvador.
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conditions: those requiring sustained care (chronic), those
treated with episodic care (acute) and those for which ac-
cess to healthcare can prevent incident cases (preventable)
across countries for women and men. In general, median
amenable-mortality rates were higher for men compared
with women. For both men and women, Mexico,
Colombia and Brazil had the highest amenable-mortality
rates, ranging from 356 to 1059 per 100 000 in women
and from 538 to 1360 in men. Argentina, Costa Rica,
Panama and Chile generally had lower amenable rates,
with rates ranging from 269 to 640 and 512 to 937 per
100 000 in women and men, respectively. Last, cities in El
Salvador and Peru had the lowest amenable-mortality rates
ranging from 160 to 464 and from 274 to 710 per 100 000
in women and men, respectively. This pattern of countries
with high, intermediate and low mortality was similar for
acute and chronic amenable-mortality rates. Acute and
chronic amenable mortalities in Peru and El Salvador were
particularly low. The pattern was different for preventable
amenable mortality; Colombia, Panama and El Salvador
had the highest preventable mortality rates among women
and men. Argentina, Chile and Costa Rica had the lowest
rates of preventable amenable mortality.
Figures 1 and 2 also show that a sizable proportion of
the variation in amenable mortality due to acute conditions
(ICC¼ 64% and 76%, for women and men, respectively)
and chronic conditions (ICC¼ 59% and 67%) is due to
between-country heterogeneity. For amenable mortality
Figure 2. Amenable-mortality rates in 363 Latin American cities. AR, Argentina; BR, Brazil; CL, Chile; CO, Colombia; CR, Costa Rica; MX, Mexico; PA,
Panama; PE, Peru; SV, El Salvador.
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due to preventable causes, only 28% and 37% of the vari-
ability in rates, respectively for women and men, was due
to between-country heterogeneity, meaning that most of
the variability in preventable amenable mortality occurs
between cities within countries.
Table 2 shows the adjusted associations between predic-
tors and amenable mortality among women and men from
the final model. We found an interaction between popula-
tion size and patch density, and retained it in the final
models. In average-sized cities (275 000), higher frag-
mentation was associated with lower amenable mortality:
a 1-SD higher patch density was associated with 3.4% and
1.7% lower amenable mortality among women and men,
respectively. However, the direction of the association be-
tween patch density and amenable mortality changed from
negative to positive and became stronger as the population
increased (Figure 3). Analogously, the association between
city size and amenable mortality also differed at different
levels of fragmentation. Among cities with average frag-
mentation, a larger population was associated with a lower
amenable-mortality rate in women but higher amenable
mortality in men; a 50% larger population in a city with
the mean patch density was associated with a 0.6% lower
[95% confidence interval (CI) –0.5% to 1.6%] and a 0.1%
higher (95% CI –0.9% to 1.0%) amenable mortality
among women and men, respectively. The association of
city size and amenable mortality became more positive and
stronger at higher levels of fragmentation.
A 1-SD higher SES index was associated with a 3.3%
and 3.2% lower amenable mortality among women and
men, respectively. Finally, a 1-SD higher population
growth, measured as a percentage change from the first
and the last year, was associated with 2.7% and 2.0%
lower amenable mortality among women and men,
respectively.
The groups of amenable mortality (chronic, acute and
preventable) had generally similar patterns of association
with predictors, with some important caveats (Figure 4). A
larger population size was associated with a higher mortal-
ity rate by preventable conditions in both women and men,
but with a lower chronic amenable-mortality rate in men.
Positive population growth was associated with lower
chronic amenable mortality, but not associated with acute
or preventable amenable mortality. Last, the interaction
between population size and fragmentation was observed
for acute amenable mortality only.
The results from the sensitivity analyses excluding El
Salvador and Peru showed estimates that were broadly
consistent with the main analysis (Supplementary Figure
S3, available as Supplementary data at IJE online).
Discussion
Rates of healthcare amenable mortality varied greatly in
Latin American cities, from <400 to >900 deaths per 100
000 people. More than two-thirds of the variation in ame-
nable-mortality rates was due to between-country hetero-
geneity, whereas a third was due to heterogeneity between
cities within countries. Cities in Mexico, Colombia and
Brazil had the highest rates of amenable mortality due to
acute and chronic conditions, whereas cities in Argentina,
Chile and Panama had lower amenable-mortality rates
compared with cities in other countries. Cites in El
Salvador and Peru had lower amenable-mortality rates
than most other countries but higher mortality rates due to
preventable causes, those for which the healthcare system
can prevent cases. We found that higher urban-develop-
ment fragmentation was associated with lower amenable
mortality in smaller cities but higher amenable mortality in
larger cities. We also found that faster population growth
Table 2. Percent differences in amenable mortality associated with urban metrics among women and men in 363 Latin
American cities
Women Men
Population (% difference in mortality for a 50% difference
in population in a city with the mean patch density)
–0.6% 0.1%
[–0.5%, 1.6%] [–0.9%, 1.0%]
Patch density (% difference in mortality for a 1-SD difference
in patch density for a city with population 275 000)
–3.4% –1.7%
[–5.9%, –0.7%] [–4.1%, 0.8%]
Population  patch density 0.02 0.01
[0.000, 0.034] [–0.004, 0.028]
Growth (% difference in mortality for a 1-SD difference
in % growth)
–2.7% –2.0%
[–4.3%, –1.0%] [–3.5%, –0.4%]
SEI (% difference in mortality for a 1-SD difference
in the Socioeconomic Index)
–3.3% –3.2%
[–5.4%, –1.2%] [–5.2%, –1.2%]
95% confidence intervals in brackets. Models were run 100 times with the redistributed mortality rates for each city and coefficients were pooled using Rubin’s
formula. Population size was centred at the median (275 000). Models were adjusted for % built up and country. SEI, Socioeconomic Index; SD, standard
deviation.
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and higher city-level SES were associated with lower ame-
nable mortality.
A potential explanation for the large proportion of
between-country variability in amenable mortality is re-
lated to differences in the healthcare systems across the
countries. Latin American countries vary in the financing
and organization of their healthcare systems.6 Argentina,
Chile and Panama have the highest healthcare spending
from government or compulsory contributory schemes
(mainly social security), at $1100 per capita in 2016 ad-
justed for purchase power parity (PPP).32 Brazil, Mexico
and Colombia had relatively low healthcare expenditures
coming from government/compulsory schemes, at $500
per capita in Brazil and Mexico and $700 per capita in
Colombia. Peru and El Salvador had the lowest healthcare
expenditure, at $400 per capita adjusted for PPP.32 Our
amenable-mortality results are generally consistent with
the pattern of healthcare spending across countries: the
lower the healthcare spending, the more amenable mortal-
ity was observed. Peru and El Salvador are exceptions to
this pattern, which may be explained by issues around the
quality of vital-statistics systems in these countries.
Although excluding cities from the two countries did not
affect the overall associations, inferences about the amena-
ble-mortality rates in these cities are limited by data-qual-
ity issues. Differences in behavioural factors across
countries and cities may also play a role in the
Figure 3. Predicted coefficients of association of fragmentation (patch density) with amenable mortality on population size derived from interactions
in Table 2
Men Women








Figure 4. Estimates from final models by sex and groups of amenable
mortality in 363 Latin American cities. SES, socio-economic status.
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heterogeneity seen in amenable mortality. Heterogeneity in
the prevalence of behavioural and cardiometabolic risk
factors in Latin American cities33–35 is likely to lead to var-
iations in amenable mortality above and beyond the role of
healthcare systems.
Previous studies examining amenable mortality have fo-
cused on high-income countries and used different lists of
causes of death to classify amenable mortality, precluding
direct comparison with our results. A small number of
studies have examined amenable mortality in low- and
middle-income countries using adapted lists of amenable
conditions. Kruk et al.2 estimated that in 2016 a total of
8.6 million deaths were amenable to healthcare in 137
countries. However, this paper applied a different method-
ology to calculate age-adjusted amenable-mortality rates
and focused only on country-level metrics. Our study
allowed the examination of variability in amenable mortal-
ity across cities as well as city-level predictors of amenable
mortality.
For all amenable mortality, we found an interaction be-
tween patch density, a measure of urban-development
fragmentation, and population size, such that higher frag-
mentation was associated with higher amenable mortality
in larger cities (and, analogously, a larger city size was as-
sociated with higher amenable mortality in more frag-
mented cities). One potential explanation for this finding is
that high urban-development fragmentation can represent
geographic barriers for city residents living in peripheral
areas of large urban centres.10 In smaller cities, however,
higher fragmentation was associated with lower amenable
mortality. Fragmentation may also mean that interstitial
spaces, likely to be green,36 provide opportunities for men-
tal restoration and physical activity. Indeed, fragmentation
of urban development has been associated with decreased
noise,37 lower heat-island effects38 and better air quality.39
Future studies should examine the associations of urban
metrics with specific causes of deaths to empirically test
these potential explanations in large and small cities. An
interesting finding was that population size was associated
with higher amenable mortality due to preventable condi-
tions regardless of fragmentation. This could be related to
the higher prevalence of some causes of preventable ame-
nable mortality (e.g. tuberculosis) in denser areas.40
Finally, population growth, which was associated with
lower amenable mortality, may be a proxy for thriving cit-
ies with a large share of the workforce formally
employed.23
To our knowledge, this is the first study to examine the
associations of urban-development fragmentation and city
size with amenable mortality. In our sample of cities, frag-
mentation was much higher in cities with 1 million peo-
ple. This may indicate the challenge of managing urban
growth in larger cities effectively. Larger cities generally
have lower mortality rates but important variations across
neighbourhoods may exist.29 Further examination of mor-
tality variation across neighbourhoods within cities is
needed to identify areas with relatively high and low mor-
tality, and whether patterns of amenable mortality within
cities are associated with access to healthcare. Our results
also showed that cities with higher SES (proxied by levels
of educational achievement) had on average lower amena-
ble mortality. Educational attainment is known to predict
access to important resources and affect several health out-
comes via multiple mechanisms.41 One potential mecha-
nism is higher education leading to access to high-quality
healthcare, which can mitigate death and disability. Future
studies should examine causal mechanisms in specific
groups or amenable conditions.
A limitation of our study is the use of administrative
units that contained the urban footprint of the city, which
in some countries led to large units of analysis that in-
cluded some undeveloped areas. Even though we adjusted
for the percentage of the area that is built, this may have
led to misspecification of the urban constructs in our anal-
yses. A number of other factors that may be relevant pre-
dictors of healthcare amenable mortality, including those
related to healthcare access and quality,2 were not included
in our analysis. In addition, we did not adjust for cardio-
metabolic and behavioural factors that contribute to the
overall burden of disease, such as smoking and obesity,
given the challenges involved in obtaining city-level preva-
lence rates of these factors across several countries. Under-
reporting of deaths and ill-defined codes are still important
issues limiting the quality of the mortality data worldwide
and vary considerably across countries. To address ill-
defined codes, we used proportional redistribution by age,
sex, country and year, following the GHE method.28 We
chose this approach due to its relative simplicity, as op-
posed to the more complex42 Global Burden of Disease
(GBD) method.43 The quality of mortality estimates has
been shown to depend on the quality of vital registration,44
which according to GBD is very high in the countries in
which 337 of our 363 cities are located.43 However, de-
spite these steps, we cannot completely rule out the possi-
bility of bias resulting from these issues. Future studies
should consider leveraging new methodologies to address
completeness, including model-based estimates of com-
pleteness45 and more detailed examination of ill-defined
codes.46 We believe that the use of mortality data at the
subnational level can help to identify and address issues of
quality and completeness, and help to advocate for im-
proved data quality.23,47
In conclusion, we found that sex-specific age-adjusted
amenable-mortality rates vary greatly across 363 cities
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of >100 000 people in nine Latin American countries.
However, most of the total variability in amenable mor-
tality was due to between-country heterogeneity, likely
due to differences in macro determinants of health across
countries as well as country-level healthcare-system fac-
tors. Urban metrics such as population size, population
growth, fragmentation of urban development and city-
level SES may have a role in the occurrence of amenable
mortality. Specifically, high levels of urban fragmenta-
tion are a potential indicator of geographical barriers to
healthcare in large urban centres, which in turn may lead
to high amenable mortality in large cities with high frag-
mentation. Understanding the links between urban met-
rics and city residents’ health may provide valuable
evidence to urban planners and public health practi-
tioners looking to plan healthier cities and improve ac-
cess to healthcare.
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13. Hong H, Mújica OJ, Anaya J, Lansingh VC, López E, Silva JC.
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